【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 16
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Overview 25
3.2 Etiology and Pathophysiology 26
3.2.1 Etiology 26
3.2.2 Pathophysiology 33
3.3 Symptoms 35
3.4 Prognosis 36
3.4.1 Phases of Chronic HBV Infection 37
3.4.2 Complications of Chronic Hepatitis B 41
3.5 Quality of Life 43
4 Epidemiology 45
4.1 Disease Background 45
4.2 Risk Factors and Comorbidities 46
4.3 Global Trends 47
4.4 Forecast Methodology 49
4.4.1 Sources Used 50
4.4.2 Sources Not Used 58
4.4.3 Forecast Assumptions and Methods 59
4.5 Epidemiological Forecast of Chronic Hepatitis B (2014-2024) 65
4.5.1 Diagnosed Prevalent Cases of Chronic Hepatitis B 65
4.5.2 Age-Specific Diagnosed Prevalent Cases of Chronic Hepatitis B 67
4.5.3 Sex-Specific Diagnosed Prevalent Cases of Chronic Hepatitis B 70
4.5.4 Age-Standardized Diagnosed Prevalence of Chronic Hepatitis B 72
4.5.5 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by HBV DNA Level 74
4.5.6 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by ALT Level 75
4.5.7 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by HBeAg Status 76
4.5.8 Diagnosed Prevalent Cases of Chronic Hepatitis B Segmented by Cirrhosis Status 77
4.5.9 Diagnosed Prevalent Cases of Chronic Hepatitis B with Co-infection of HIV and Hepatitis C 79
4.6 Discussion 80
4.6.1 Epidemiological Forecast Insight 80
4.6.2 Limitations of the Analysis 80
4.6.3 Strengths of the Analysis 81
5 Disease Management 82
5.1 Diagnosis and Treatment Overview 82
5.1.1 Diagnosis 82
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 83
5.1.3 Clinical Practice 85
5.2 US 90
5.2.1 Screening and Diagnosis 91
5.2.2 Clinical Practice 92
5.3 5EU 95
5.3.1 Screening and Diagnosis 96
5.3.2 Clinical Practice 97
5.4 Japan 101
5.4.1 Screening and Diagnosis 101
5.4.2 Clinical Practice 103
5.5 China 106
5.5.1 Screening and Diagnosis 107
5.5.2 Clinical Practice 109
6 Competitive Assessment 113
6.1 Overview 113
6.2 Product Profiles – Major Brands 117
6.2.1 Baraclude (entecavir) 117
6.2.2 Viread (tenofovir disoproxil fumarate) 122
6.2.3 Pegasys (peginterferon alfa-2a) 130
6.2.4 Hepsera (adefovir dipivoxil) 137
6.2.5 Tyzeka (telbivudine) 141
6.3 Other Therapeutics 147
6.3.1 Conventional and Pegylated Interferon alfa 147
6.3.2 Nucleos(t)ide Analogs 148
7 Unmet Needs and Opportunities 150
7.1 Overview 150
7.2 Improvements in Long-Term Clinical Outcomes 153
7.2.1 Unmet Need 153
7.2.2 Gap Analysis 156
7.2.3 Opportunity 160
7.3 Enhanced Public Awareness and Screening Initiatives to Boost Diagnosis Rates 163
7.3.1 Unmet Need 163
7.3.2 Gap Analysis 167
7.3.3 Opportunity 167
7.4 Increased Access to Treatment 168
7.4.1 Unmet Need 168
7.4.2 Gap Analysis 171
7.4.3 Opportunity 172
7.5 Drugs That Effectively Target and Suppress HBV cccDNA 173
7.5.1 Unmet Need 173
7.5.2 Gap Analysis 173
7.5.3 Opportunity 174
7.6 Safe and Efficacious Therapies for Difficult-to-Treat Patients 175
7.6.1 Unmet Need 175
7.6.2 Gap Analysis 176
7.6.3 Opportunity 177
7.7 Overcome Unique Barriers Posed by China’s Healthcare System 178
7.7.1 Unmet Need 178
7.7.2 Gap Analysis 179
7.7.3 Opportunity 179
8 Pipeline Assessment 181
8.1 Overview 181
8.2 Clinical Trial Mapping 182
8.2.1 Clinical Trials by Phase and Status, Therapy Class, and Location 182
8.3 Promising Drugs in Clinical Development 184
8.3.1 Tenofovir Alafenamide Fumarate 187
8.3.2 ARC-520 194
8.3.3 GS-9620 201
8.3.4 GS-4774 206
8.4 Other Drugs in Development 212
8.4.1 ABX-203 213
8.4.2 REP 2139-Ca 214
8.4.3 Besifovir 215
8.4.4 Hepabulin 215
8.4.5 Myrcludex-B 215
8.4.6 Agents in Early Stages of Development 216
9 Current and Future Players 219
9.1 Overview 219
9.2 Trends in Corporate Strategy 222
9.3 Company Profiles 225
9.3.1 Gilead 225
9.3.2 Bristol-Myers Squibb 227
9.3.3 Roche 229
9.3.4 Merck 230
9.3.5 GSK 233
9.3.6 Novartis 234
9.3.7 Arrowhead Research 235
9.3.8 GlobeImmune 236
10 Market Outlook 237
10.1 Global Markets 237
10.1.1 Forecast 237
10.1.2 Drivers and Barriers – Global Issues 243
10.2 US 245
10.2.1 Forecast 245
10.2.2 Key Events 249
10.2.3 Drivers and Barriers 250
10.3 5EU 252
10.3.1 Forecast 252
10.3.2 Key Events 256
10.3.3 Drivers and Barriers 257
10.4 Japan 260
10.4.1 Forecast 260
10.4.2 Key Events 264
10.4.3 Drivers and Barriers 265
10.5 China 266
10.5.1 Forecast 266
10.5.2 Key Events 270
10.5.3 Drivers and Barriers 271
11 Appendix 274
11.1 Bibliography 274
11.2 Abbreviations 296
11.3 Methodology 302
11.4 Forecasting Methodology 302
11.4.1 Total Prevalent Cases of Chronic Hepatitis B 302
11.4.2 Diagnosed Chronic Hepatitis B Patients 303
11.4.3 Percent Drug-Treated Chronic Hepatitis B Patients 303
11.4.4 Drugs Included in Each Therapeutic Class 304
11.4.5 Launch and Patent Expiry Dates 304
11.4.6 General Pricing Assumptions 305
11.4.7 Individual Drug Assumptions 307
11.4.8 Generic Erosion 314
11.4.9 Pricing of Pipeline Agents 315
11.5 Primary Research – KOLs Interviewed for this Report 316
11.6 Primary Research – Prescriber Survey 319
11.7 About the Authors 320
11.7.1 Analyst 320
11.7.2 Therapy Area Director 320
11.7.3 Epidemiologists 321
11.7.4 Global Director of Therapy Analysis and Epidemiology 321
11.7.5 Global Head of Healthcare 321
11.8 About GlobalData 322
11.9 Disclaimer 322
【レポート販売概要】
■ タイトル：B型肝炎ウイルス（HBV）治療薬の世界市場予測・分析（～2024）■ 英文：PharmaPoint: Hepatitis B Virus (HBV) Therapeutics - Global Drug Forecast and Market Analysis to 2024
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDHC117PIDR
■ 調査対象地域：グローバル
- Anthocyaninの世界市場Anthocyanin (CAS 13329-14-1) Market Research Report 2013 presents comprehensive data on anthocyanin markets globally and regionally (Europe, Asia, North America etc.) The Anthocyanin (CAS 13329-14-1) Market Research Report 2013 includes anthocyanin description, covers its application areas and related patterns. It overviews anthocyanin market, names anthocyanin producers and indicates its supplier …
- インドのシリカフューム市場：用途別、ソース別Silica Fume Market in India: About this market Technavio’s silica fume market in India analysis considers sales from construction, marine, oil and gas, and other applications. Our study also finds the sales of silica fume from silicon metal and ferrosilicon sources. In 2019, the construction segment had a significant market share, and this trend is expected to continue over the forecast period. Fa …
- ホルモン感受性乳癌：世界の臨床試験レビュー（2014年上半期）Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hormone Sensitive Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone Sensitive Breast Cancer. It includes …
- ジェネレーティブデザインの世界市場予測（～2023年）Rising need for advanced product design software to drive product innovation is driving the growth of the marketThe global generative design market to grow from USD 111 million in 2018 to USD 275 million by 2023, at a CAGR of 19.9% during the forecast period. The generative design market is growing rapidly with the rising need for advanced product design software, growing demand for environment-fr …
- 繊維セメントの世界市場2015-2022According to Stratistics MRC, the Global Fiber Cement market is estimated at $13.15 billion in 2015 and is expected to grow at a CAGR of 5.56% to reach $19.2 billion by 2022. The factors such as hasty increase in construction industries & other infrastructures, conventions against the use of Asbestos and fiber cement having advantages over alternatives are some of the drivers fueling the market gr …
- クーリング織物の世界市場予測（～2021年）：スポーツ衣類、保護服、ライフスタイルThe cooling fabrics market was valued at USD 1.80 Billion in 2016 and is projected to reach USD 2.94 Billion by 2021, at a CAGR of 10.3% from 2016 to 2021. The growth of the cooling fabrics market is mainly attributed to the growing demand from sportswear and protective wearing market applications. Major applications in the cooling fabrics market include sports apparel, protective wearing, lifesty …
- ポリオレフィン (polyolefin)業界動向分析：February 2013Polyolefins World – February 2013 Summary The global polyolefins market witnessed a stable supply demand scenario in February 2013. The supply of both Polyethylene (PE) and Polypropylene (PP) was sufficient to meet demand. Feedstock olefins prices were relatively stable in February and brought no significant increase in polyolefins prices. Scope - Analyses monthly price trends in Asia and North Am …
- 血液型判定の世界市場2019-2023About this market In recent years, the increasing prevalence of chronic diseases such as diabetes and cancer among individuals is leading to a rising demand for early diagnosis for better patient care. Blood group testing is necessary for cancer patients, as the disease may require blood transfusion for treatment. Blood products such as platelets used for treating cancer patients have a shorter sh …
- 資産管理ソリューションの世界市場：IT資産、輸送資産、製造資産等The Asset Management System market report has been segmented by function, which include: location/ movement tracking, check in & out, repair & maintenance and others. By asset type it includes: IT assets, returnable transport, in-transit equipment, manufacturing asset, and personnel/ staff. By technology it includes: Radio-frequency identification (RFID), Real-Time Locating System (RTLS), Global P …
- パーム油メチルエステルの世界市場The global palm methyl ester derivatives market is anticipated to reach USD 1.01 billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for CPO and PKO derived products from a wide range of sectors including personal care, home care, and food along with other industrial products such as adhesives, lubricants, paints, coatings, and inks is expected to influence produ …
- ミート・スナックの世界市場2016-2020About Meat Snacks The global meat snacks market is growing because of various factors such as demand for low calorie and high protein content food products and growing health and fitness awareness among consumers. The meat snacks market consists of various products such as jerkies, sticks, sausages, and others. The convenience of meat snacks such as portable packaging and smaller pack size, which …
- Energen Corporation：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Energen Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Energen Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 2014 World Animal Health Market Dynamics, Trends, and Leading Supplier Marketing Tactics and Technological Know-HowThis new 80-pages report from Venture Planning Group analyzes marketing tactics and technological know-how of the world’s leading animal health companies, including: Five-year forecasts for: - Major market segments - Key geographic regions Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, …
- 腫瘍アブレーションの世界市場予測（～2021年）：ラジオ波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IREアブレーション、超音波アブレーション、レーザアブレーションThe global tumor ablation market is expected to reach a value of USD 580.1 Million by 2021, at a CAGR of 12.5% during 2016-2021. A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growin …
- レディーミックスコンクリートの世界市場2019-2023Global Ready-mix Concrete Market: About this market Ready-mix concrete is a construction material manufactured in a factory or a plant within specific guidelines such as 3 parts aggregates, 2 parts water, and 1-part cement. Technavio’s ready-mix concrete market analysis considers sales from both non-residential and residential. Our analysis also considers the sales of ready-mix concrete in APAC, E …
